Institution statistics

ASTRAZENECA - United Kingdom 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:600-700
Total Number of Projects:100-200
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 72
As coordinator: 0
As participant: 72
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 19.163.059 1.854.079 5
2020 0 38.904.431 1.086.449 7
2019 0 138.270.918 1.494.210 10
2018 0 72.982.307 0 8
2017 0 66.648.068 0 7
2016 0 37.769.192 0 9
2015 0 10.088.161 0 3
2014 0 3.301.294 0 1
2013 0 32.185.152 1.876.531 9
2012 0 18.049.810 136.203 5
2011 0 29.398.001 0 5
2010 0 16.769.994 0 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA10
BAYER9
JANSSEN PHARMACEUTICA NV9
PFIZER LIMITED8
KATHOLIEKE UNIVERSITEIT LEUVEN7
SANOFIAVENTIS7
F HOFFMANNLA ROCHE6
UCB BIOPHARMA5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
KAROLINSKA INSTITUTE4
TAKEDA DEVELOPMENT CENTRE EUROPE4
TAKEDA PHARMACEUTICALS INTERNATIONAL4
UNIVERSITAET ZUERICH4
UPPSALA UNIVERSITET4
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
ELI LILLY AND COMPANY LIMITED3
FORUM DES PATIENTS EUROPEENS3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
MERCK SHARP & DOHME CORP3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITY OF CAMBRIDGE3
UNIVERSITY OF NEWCASTLE UPON TYNE3
ABBVIE INC2
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ALLERGAN LIMITED2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CLINIQUES UNIVERSITAIRES SAINTLUC2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DREEM2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGENNUERNBERG2
GRUNENTHAL2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
INSTITUTO SUPERIOR TECNICO2
IXSCIENT LIMITED2
LEIDEN UNIVERSITY2
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MCROBERTS BV2
MEDIZINISCHE UNIVERSITAET WIEN2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NOVO NORDISK2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
SERVICIO MADRILENO DE SALUD2
STICHTING MLC FOUNDATION2
STICHTING VUMC2
SYDDANSK UNIVERSITET2
TEAM IT RESEARCH SL2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
UNIVERSIDAD POLITECNICA DE MADRID2
UNIVERSIDAD POMPEU FABRA2
UNIVERSITA DEGLI STUDI DI GENOVA2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAET BASEL2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITAT WIEN2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT GENT2
UNIVERSITEIT TWENTE2
UNIVERSITEIT UTRECHT2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF OSLO2
UNIVERSITY OF SOUTHAMPTON2
A PERSIDIS & SIA OE1
ABO AKADEMI1
ACCADEMIA EUROPEA PER LA RICERCA APPLICATA ED IL PERFEZIONAMENTO PROFESSIONALE BOLZANO1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AKERSHUS UNIVERSITETSSYKEHUS HF1
ALACRIS THERANOSTICS1
ALCEDIAG1
AMGEN LIMITED1
AMGEN RESEARCH1
ARTEEVO TECHNOLOGIES1
ASOCIACION PARKINSON MADRID1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ATRYS HEALTH1
AZIENDA OSPEDALE UNIVERSITA PADOVA1
Constancy:

Total number of partners:506

Partner loyalty:
Frequent Partner: (> 2 projects): 135
Rare Partner: 371

Frequent / Rare Partner Ratio: 0.36

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Boosting advanced doctoral training in innovative colon targeting drugs COLOTANparticipant3.533.10810
2021-01-01EU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseases EndoConnectparticipant4.074.58912
2021-01-01Oligonucleotides for Medical Applications OLIGOMEDparticipant4.153.34412
2021-01-01Advanced machine learning for Innovative Drug Discovery AIDDparticipant3.926.61515
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.475.40211
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-09-01NExt ApplicationS of Quantum Computing NEASQCparticipant4.671.33312
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-07-01C-H Activation for Industrial Renewal CHAIRparticipant3.938.27014
2020-02-01Cooperation towards a sustainable chemical industry CO2PERATEparticipant4.156.28710
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPparticipant999.7106
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-01-01Stirling heat pump for high temperature industrial use Highliftparticipant2.439.5123
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-04-01DNA as a training platform for photodynamic processes in soft materials LightDyNAmicsparticipant3.827.59113
2018-03-01Nonlocal Methods for Arbitrary Data Sources NoMADSparticipant1.111.50025
2018-01-01Big Data for Medical Analytics BigMedilyticsparticipant14.997.30635
2018-01-01Big Data for Medical Analytics BigMedilyticsparticipant14.997.30635
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-09-01Improving Genome Editing Efficiency (IMGENE) IMGENEparticipant2.068.40910
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01Molecular Tools for Nucleic Acid Manipulation for Biological Intervention MMBioparticipant3.971.34819
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-06-01PET Imaging in Drug Design and Development PET3Dparticipant3.901.24810
2016-02-01Targeted small-molecule Stabilisation of Protein-Protein Interactions TASPPIparticipant3.342.32312
2016-01-01Accelerated Early staGe drug diScovery AEGISparticipant3.836.99626
2016-01-01ISOTOPIC LABELING FOR DRUG INNOVATION ISOTOPICSparticipant3.948.84413
2016-01-01Non-Noble Metal Catalysis - NoNoMeCat NoNoMeCatparticipant3.318.63415
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617
2015-11-01Synaptic Dysfunction in Alzheimer Disease SyDADparticipant3.846.73611
2015-09-01Exascale Compound Activity Prediction Engine ExCAPEparticipant3.910.1409
2015-01-01Advanced XFEL and Synchrotron based Probes of Protein Structure and Dynamics X-probeparticipant2.331.2859
2014-03-01"FLUOR21 : Synthesis, structure and function of fluorinated systems" FLUOR21participant3.301.2949

overview shows latest 50 from 72 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • ASTRAZENECA
  • ASTRAZENECA AB
  • ASTRAZENECA INDIA PVT
  • ASTRAZENECA UK LIMITED

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum